Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2023 · 10-Q
Revenue$10.71B$10.71B−9.4% vs Q1 2022 Net Income$1.29B$1.29B−41.8% vs Q1 2022 EPS Diluted$3.32$3.32−40.8% vs Q1 2022 Operating Income$1,563,000,000−44.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Free Cash Flowderived$271,000,000−82.7% Margins · derivedOperating margin14.6%−9.3 pt vs Q1 2022
Net margin12.1%−6.7 pt vs Q1 2022
ended Apr 1, 2023 · filed May 5, 2023 · 34 d after period end